Senior Clinical Trial Manager New

Beeline Medicines is a clinical‑stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people living with autoimmune and inflammatory diseases. With a portfolio of potential best-in‑class and first-in-disease therapeutic candidates that directly target key pathways governing dysregulated immunological and inflammatory responses, the Company is developing medicines that have the opportunity to provide durable, life-changing impact.

Led by an established executive team and backed by world‑class life science investors, each day Beeline Medicines is determined to bring the scientific rigor and operational excellence to get to what matters for patients – realizing a world where people with immune‑mediated diseases can live life fully.

The Senior Clinical Trial Manager (Sr. CTM) will lead the operational planning, execution, and oversight of complex, global clinical studies in the field of immunology and autoimmune diseases. This role is responsible for ensuring studies are delivered on time, within scope, and in compliance with regulatory standards, Good Clinical Practice (GCP), and company Standard Operating Procedures (SOPs). The Sr. CTM will partner closely with internal cross‑functional teams (Clinical Development, Regulatory, Biometrics, Safety, and Quality) and external partners (CROs, vendors, and sites) to ensure operational excellence.

This individual will also play a critical role in driving strategic decision‑making and supporting inspection readiness and regulatory submissions.

Remote - This position is designated as remote; the incumbent will be expected to travel to Beeline Medicines’ offices on a periodic basis to support in‑person collaboration, team engagement, and business operations. The frequency and scheduling of such visits will be determined at the company's discretion based on business need.

• Lead the operational strategy, planning, and execution of global Phase 1–4 clinical trials in immunology indications (e.g., autoimmune and inflammatory diseases).
• Serve as the primary operational point of contact for internal stakeholders and external partners.
• Oversee the selection and management of CROs and other vendors, including scope of work, budget development, contracting, and performance oversight.
• Drive site feasibility, site selection, activation, patient recruitment strategies, and ongoing site management to ensure achievement of enrollment goals.
• Develop and maintain study timelines, risk mitigation strategies, and operational tracking tools.
• Collaborate with cross‑functional teams on protocol development, CRF design, ICF review, and development of operational study plans.
• Ensure studies are conducted in compliance with GCP/ICH guidelines, local regulatory requirements, and internal SOPs.
• Proactively identify and resolve operational issues, escalating risks and implementing mitigation strategies as needed.
• Oversee data collection activities, database lock readiness, and support data review processes.
• Contribute to regulatory filings, inspection readiness, and audit preparation.
• Provide leadership and mentorship to Clinical Operations team members.
• Contribute to process improvement initiatives within Clinical Operations to enhance efficiency and quality.
• Perform other duties and responsibilities as assigned

• Education:
  
  Bachelor’s degree in life sciences or related field (advanced degree preferred)
• Minimum 5 years of experience in clinical operations in the biopharmaceutical industry, with at least 3 years in a Senior CTM or equivalent leadership role.
• Proven track record of managing global, multi‑center clinical trials in immunology or autoimmune disease indications.
• Experience with biologics, monoclonal antibodies, or advanced therapies.
• Strong knowledge of GCP/ICH guidelines, clinical trial regulations, and operational best practices.
• Experience in rare autoimmune indications or immune‑mediated inflammatory diseases.
• Familiarity with adaptive trial designs or complex biomarker‑driven studies.
• Experience in early‑to late‑stage…